S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Celgene Corporation (CELG)
Celgene Corporation (CELG) News

CELG

Celgene (CELG)

Celgene Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CELG

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
12/16/2019	6:30AM	GlobeNewswire Inc.	NexImmune Appoints Sol Barer as Chairman of the Board of Directors	NASDAQ:CELG	Celgene Corporation
11/21/2019	5:21AM	PR Newswire (US)	Amgen Completes Acquisition Of Otezla® (apremilast)	NASDAQ:CELG	Celgene Corporation
11/20/2019	3:18PM	Business Wire	Celgene Announces Plans to Transfer Listing of Celgene’s Contingent Value Rights Following Closing of Acquisition by Bristo...	NASDAQ:CELG	Celgene Corporation
11/20/2019	1:09PM	Business Wire	CELGENE ERHÄLT DIE ZULASSUNGSEMPFEHLUNG DES CHMP FÜR LENALIDOMID (REVLIMID®) IN KOMBINATION MIT RITUXIMAB ZUR BEHANDLUNG V...	NASDAQ:CELG	Celgene Corporation
11/19/2019	10:16AM	PR Newswire (US)	Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500	NASDAQ:CELG	Celgene Corporation
11/18/2019	4:10PM	GlobeNewswire Inc.	Exelon Corporation to Join the NASDAQ-100 Index Beginning November 21, 2019	NASDAQ:CELG	Celgene Corporation
11/15/2019	4:39PM	Dow Jones News	FTC Requires Bristol-Meyers Squibb, Celgene to Divest Otezla as Condition of Acquisition	NASDAQ:CELG	Celgene Corporation
11/15/2019	7:22AM	Dow Jones News	Celgene Gets CHMP Positive Opinion for Revlimid/Rituximab Combo in Follicular Lymphoma	NASDAQ:CELG	Celgene Corporation
11/15/2019	6:30AM	Business Wire	Celgene Receives CHMP Positive Opinion for REVLIMID® (lenalidomide) in Combination With Rituximab for the Treatment of Adult...	NASDAQ:CELG	Celgene Corporation
11/12/2019	9:28PM	PR Newswire (Canada)	Skyhawk Therapeutics annonce une deuxième entente de collaboration multicible avec Celgene pour découvrir et mettre au poin...	NASDAQ:CELG	Celgene Corporation
11/12/2019	8:00AM	PR Newswire (US)	Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...	NASDAQ:CELG	Celgene Corporation
11/12/2019	8:00AM	PR Newswire (Canada)	Skyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene to Discover and Develop Novel Small...	NASDAQ:CELG	Celgene Corporation
11/08/2019	12:30PM	Dow Jones News	Acceleron Pharma Shares Gain Ground After FDA Approves Reblozyl	NASDAQ:CELG	Celgene Corporation
11/08/2019	12:20PM	Dow Jones News	FDA Approves Celgene's and Acceleron's Reblozyl to Treat Rare Blood Disorder	NASDAQ:CELG	Celgene Corporation
11/08/2019	11:33AM	Business Wire	FDA Approves REBLOZYL® (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular R...	NASDAQ:CELG	Celgene Corporation
11/06/2019	3:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
11/06/2019	8:06AM	Business Wire	Celgene to Present New & Updated Data on Key Hematology Pipeline Therapies at American Society of Hematology (ASH) 2019 Annua...	NASDAQ:CELG	Celgene Corporation
11/04/2019	3:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
11/04/2019	3:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
11/04/2019	3:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
11/04/2019	3:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
11/04/2019	3:10PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
10/31/2019	3:05PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CELG	Celgene Corporation
10/31/2019	6:37AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELG	Celgene Corporation
10/31/2019	6:30AM	Business Wire	Celgene Reports Third Quarter 2019 Operating and Financial Results	NASDAQ:CELG	Celgene Corporation
10/16/2019	5:00AM	Business Wire	Celgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...	NASDAQ:CELG	Celgene Corporation
09/20/2019	6:30AM	Business Wire	Celgene Corporation Names Second Round of Celgene Cancer Care Links™ Program Grant Recipients	NASDAQ:CELG	Celgene Corporation
09/19/2019	3:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELG	Celgene Corporation
09/12/2019	3:30PM	Business Wire	Celgene Announces Phase 3 QUAZAR® AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myel...	NASDAQ:CELG	Celgene Corporation
09/11/2019	11:24AM	Dow Jones News	Swiss Biotech Anokion Raises $40 Million in Series B Round	NASDAQ:CELG	Celgene Corporation

Showing the most relevant articles for your search:NASDAQ:CELG

1 2 3 4 5 6 7 8 9 10 Next >>

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Umbra Applied Technologies (PK)

Yuenglings Ice Cream (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

Ubiquitech Software (PK)

AMC Entertainment

Astra Energy (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions